Browsing by Author : 4389

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 60 of 93

This table browses all dspace content
Issue DateTitleJournal Title
2016A melanin-bleaching methodology for molecular and histopathological analysis of formalin-fixed paraffin-embeddedLABORATORY INVESTIGATION
2014A Phase 2 Trial of Radiation Therapy With Concurrent Paclitaxel Chemotherapy After Surgery in Patients With High-Risk Endometrial Cancer: A Korean Gynecologic Oncologic Group StudyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2016Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer ONCOTARGET
2010Accuracy of preoperative tests in clinical stage I endometrial cancer: the importance of lymphadenectomyACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
2019ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer CANCERS
2017API5 induces cisplatin resistance through FGFR signaling in human cancer cells EXPERIMENTAL AND MOLECULAR MEDICINE
2014Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer. BMC CANCER
2023Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer BRITISH JOURNAL OF CANCER
2015Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array DIAGNOSTIC PATHOLOGY
2014ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer YONSEI MEDICAL JOURNAL
2010Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancerGENES CHROMOSOMES & CANCER
2017Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical CancerANTICANCER RESEARCH
2020CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancerGYNECOLOGIC ONCOLOGY
2016Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer YONSEI MEDICAL JOURNAL
2015Clinical significance of OCT4 and SOX2 protein expression in cervical cancer BMC CANCER
2008Clinical significance of osteopontin expression in cervical cancerJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2013Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasiaOBSTETRICS AND GYNECOLOGY
2021Clinical Significance of Tumor Infiltrating Lymphocytes in Association with Hormone Receptor Expression Patterns in Epithelial Ovarian Cancer INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2019Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growthINTERNATIONAL JOURNAL OF HYPERTHERMIA
2024Comparison of Adverse Events Between PARP Inhibitors in Patients with Epithelial Ovarian Cancer: A Nationwide Propensity Score Matched Cohort StudyTARGETED ONCOLOGY
2018Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models CANCER RESEARCH AND TREATMENT
2021CRY1 Regulates Chemoresistance in Association With NANOG by Inhibiting Apoptosis via STAT3 Pathway in Patients With Cervical Cancer CANCER GENOMICS & PROTEOMICS
2009Diagnostic and prognostic impact of osteopontin expression in endometrial cancerCANCER INVESTIGATION
2018DNA mismatch repair protein immunohistochemistry and MLH1 promotor methylation testing for practical molecular classification and the prediction of prognosis in endometrial cancer CANCERS
2013Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancerBIOMARKERS
2010ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139INTERNATIONAL JOURNAL OF ONCOLOGY
2018Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression PLOS ONE
2014Expression of Stress-Induced Phosphoprotein1 (STIP1) is Associated with Tumor Progression and Poor Prognosis in Epithelial Ovarian CancerGENES CHROMOSOMES & CANCER
2019Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancerINTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
2008Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line.MOLECULAR AND CELLULAR BIOCHEMISTRY
2017HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor CellsCANCER RESEARCH
2023High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer ONCOLOGY REPORTS
2022HIGH EXPRESSION OF PHOSPHODIESTERASE 1 (PDE1A) PROMOTES POOR PROGNOSIS AND ASSOCIATED WITH PLATINUM BASED CHEMOTHERAPY RESISTANCE IN EPITHELIAL OVARIAN CANCERINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022HIGH EXPRESSION OF TRAFFICKING PROTEIN TRANSMEMBRANE P24 TRAFFICKING PROTEIN9 PROMOTES POOR PROGNOSIS OF EPITHELIAL OVARIAN CANCERINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022HIGH EXPRESSION OF VACUOLAR-ATPASE SUBUNIT ATP6V1B1 PROMOTES POOR PROGNOSIS AND TUMORIGENIC CHARACTERISTICS IN EPITHELIAL OVARIAN CANCERINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022High FKBPL expression contributes to cell proliferation by regulating the cell cycle and affects prognosis in ovarian cancer patientsINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2023High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2018Histomorphological and Molecular Assessments of the Fixation Times Comparing Formalin and Ethanol-Based Fixatives.JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
2020HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors NATURE COMMUNICATIONS
2012Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control studyEUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
2022Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models CANCERS
2021LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells AUTOPHAGY
2009Lipocalin2 as a diagnostic and prognostic biomarker for epithelial ovarian cancer Thesis
2009Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
2013Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancerHUMAN PATHOLOGY
2019Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian CancerCancer genomics & Proteomics
2016Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology MEDICINE
2021MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors PLOS PATHOGENS
2014MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer. BMC CANCER
2018Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance JOURNAL OF CLINICAL INVESTIGATION
2021Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial EXPERIMENTAL AND THERAPEUTIC MEDICINE
2009Molecular characterization of a new ovarian cancer cell line, YDOV-151, established from mucinous cystadenocarcinoma. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
2009Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumour marker for cervical cancer.BIOMARKERS IN MEDICINE
2022NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59 SCIENTIFIC REPORTS
2022NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
2012Nanog signaling in cancer promotes stem-like phenotype and immune evasion JOURNAL OF CLINICAL INVESTIGATION
2023Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment CANCERS
2008Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosisFERTILITY AND STERILITY
2018Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARFCELL DEATH AND DIFFERENTIATION
2016Over-expression of BMI1 is associated with favorable prognosis in cervical cancer INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
12

Browse

Links